Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 16.5 g/l;  ; arginine 9.19 g/l;  ; glycine 8.23 g/l;  ; histidine 3.84 g/l;  ; isoleucine 4.79 g/l;  ; leucine 5.83 g/l;  ; lysine 4.63 g/l;  ; methionine 3.2 g/l;  ; phenylalanine 4.47 g/l;  ; proline 5.43 g/l;  ; serine 4 g/l; threonine 3.36 g/l;  ; tryptophan 1.44 g/l;  ; tyrosine 0.32 g/l;  ; valine 4.63 g/l;   - solution for infusion - 8 % - active: alanine 16.5 g/l   arginine 9.19 g/l   glycine 8.23 g/l   histidine 3.84 g/l   isoleucine 4.79 g/l   leucine 5.83 g/l   lysine 4.63 g/l   methionine 3.2 g/l   phenylalanine 4.47 g/l   proline 5.43 g/l   serine 4 g/l threonine 3.36 g/l   tryptophan 1.44 g/l   tyrosine 0.32 g/l   valine 4.63 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 16.5 g/l;  ; arginine 9.19 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 8.23 g/l;  ; histidine 3.84 g/l;  ; isoleucine 4.79 g/l;  ; leucine 5.83 g/l;  ; lysine 4.63 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 3.2 g/l;  ; phenylalanine 4.47 g/l;  ; proline 5.43 g/l;  ; serine 4 g/l; sodium acetate trihydrate 6.8 g/l; sodium chloride 1.17 g/l; threonine 3.36 g/l;  ; tryptophan 1.44 g/l;  ; tyrosine 0.32 g/l;  ; valine 4.63 g/l;   - solution for infusion - 8 % - active: alanine 16.5 g/l   arginine 9.19 g/l   dibasic potassium phosphate 5.22 g/l glycine 8.23 g/l   histidine 3.84 g/l   isoleucine 4.79 g/l   leucine 5.83 g/l   lysine 4.63 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 3.2 g/l   phenylalanine 4.47 g/l   proline 5.43 g/l   serine 4 g/l sodium acetate trihydrate 6.8 g/l sodium chloride 1.17 g/l threonine 3.36 g/l   tryptophan 1.44 g/l   tyrosine 0.32 g/l   valine 4.63 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.7 g/l;  ; arginine 11.5 g/l;  ; glycine 10.3 g/l;  ; histidine 4.8 g/l;  ; isoleucine 6 g/l;  ; leucine 7.3 g/l;  ; lysine 5.8 g/l;  ; methionine 4 g/l;  ; phenylalanine 5.6 g/l;  ; proline 6.8 g/l;  ; serine 5 g/l; threonine 4.2 g/l;  ; tryptophan 1.8 g/l;  ; tyrosine 0.4 g/l;  ; valine 5.8 g/l;   - solution for infusion - 10 % - active: alanine 20.7 g/l   arginine 11.5 g/l   glycine 10.3 g/l   histidine 4.8 g/l   isoleucine 6 g/l   leucine 7.3 g/l   lysine 5.8 g/l   methionine 4 g/l   phenylalanine 5.6 g/l   proline 6.8 g/l   serine 5 g/l threonine 4.2 g/l   tryptophan 1.8 g/l   tyrosine 0.4 g/l   valine 5.8 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 20.7 g/l;  ; arginine 11.5 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 10.3 g/l;  ; histidine 4.8 g/l;  ; isoleucine 6 g/l;  ; leucine 7.3 g/l;  ; lysine 5.8 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 4 g/l;  ; phenylalanine 5.6 g/l;  ; proline 6.8 g/l;  ; serine 5 g/l; sodium acetate trihydrate 6.8 g/l; sodium chloride 1.17 g/l; threonine 4.2 g/l;  ; tryptophan 1.8 g/l;  ; tyrosine 0.4 g/l;  ; valine 5.8 g/l;   - solution for infusion - 10 % - active: alanine 20.7 g/l   arginine 11.5 g/l   dibasic potassium phosphate 5.22 g/l glycine 10.3 g/l   histidine 4.8 g/l   isoleucine 6 g/l   leucine 7.3 g/l   lysine 5.8 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 4 g/l   phenylalanine 5.6 g/l   proline 6.8 g/l   serine 5 g/l sodium acetate trihydrate 6.8 g/l sodium chloride 1.17 g/l threonine 4.2 g/l   tryptophan 1.8 g/l   tyrosine 0.4 g/l   valine 5.8 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 11.4 g/l;  ; arginine 6.32 g/l;  ; glycine 5.66 g/l;  ; histidine 2.64 g/l;  ; isoleucine 3.3 g/l;  ; leucine 4.02 g/l;  ; lysine 3.19 g/l;  ; methionine 2.2 g/l;  ; phenylalanine 3.08 g/l;  ; proline 3.74 g/l;  ; serine 2.75 g/l; threonine 2.31 g/l;  ; tryptophan 0.99 g/l;  ; tyrosine 0.22 g/l;  ; valine 3.19 g/l;   - solution for infusion - 5.5 % - active: alanine 11.4 g/l   arginine 6.32 g/l   glycine 5.66 g/l   histidine 2.64 g/l   isoleucine 3.3 g/l   leucine 4.02 g/l   lysine 3.19 g/l   methionine 2.2 g/l   phenylalanine 3.08 g/l   proline 3.74 g/l   serine 2.75 g/l threonine 2.31 g/l   tryptophan 0.99 g/l   tyrosine 0.22 g/l   valine 3.19 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Selandia Baru - Inggris - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - alanine 11.4 g/l;  ; arginine 6.32 g/l;  ; dibasic potassium phosphate 5.22 g/l; glycine 5.66 g/l;  ; histidine 2.64 g/l;  ; isoleucine 3.3 g/l;  ; leucine 4.02 g/l;  ; lysine 3.19 g/l;  ; magnesium chloride hexahydrate 1.02 g/l; methionine 2.2 g/l;  ; phenylalanine 3.08 g/l;  ; proline 3.74 g/l;  ; serine 2.75 g/l; sodium acetate trihydrate 4.31 g/l; sodium chloride 2.24 g/l; threonine 2.31 g/l;  ; tryptophan 0.99 g/l;  ; tyrosine 0.22 g/l;  ; valine 3.19 g/l;   - solution for infusion - 5.5 % - active: alanine 11.4 g/l   arginine 6.32 g/l   dibasic potassium phosphate 5.22 g/l glycine 5.66 g/l   histidine 2.64 g/l   isoleucine 3.3 g/l   leucine 4.02 g/l   lysine 3.19 g/l   magnesium chloride hexahydrate 1.02 g/l methionine 2.2 g/l   phenylalanine 3.08 g/l   proline 3.74 g/l   serine 2.75 g/l sodium acetate trihydrate 4.31 g/l sodium chloride 2.24 g/l threonine 2.31 g/l   tryptophan 0.99 g/l   tyrosine 0.22 g/l   valine 3.19 g/l   - synthamin infusion solutions are indicated as an adjunct in the prevention of net nitrogen loss or in the treatment of negative nitrogen balance in patients where: 1. the alimentary tract, by the oral, gastrostomy or jejunostomy route, cannot or should not be used. 2. gastrointestinal absorption of protein is impaired, or 3. metabolic requirements for protein are substantially increased, as with extensive burns.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - methionine, quantity: 2 g/l; valine, quantity: 2.9 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); isoleucine, quantity: 3 g/l; glycine, quantity: 5.15 g/l; tryptophan, quantity: 0.9 g/l; histidine, quantity: 2.4 g/l; alanine, quantity: 10.35 g/l; phenylalanine, quantity: 2.8 g/l; tyrosine, quantity: 200 mg/l; glucose, quantity: 250 g/l; threonine, quantity: 2.1 g/l; arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; serine, quantity: 2.5 g/l; proline, quantity: 3.4 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - arginine, quantity: 5.75 g/l; leucine, quantity: 3.65 g/l; sodium chloride, quantity: 0.59 g/l; glycine, quantity: 5.15 g/l; proline, quantity: 3.4 g/l; serine, quantity: 2.5 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); threonine, quantity: 2.1 g/l; glucose, quantity: 250 g/l; alanine, quantity: 10.35 g/l; dibasic potassium phosphate, quantity: 2.61 g/l; tryptophan, quantity: 0.9 g/l; phenylalanine, quantity: 2.8 g/l; histidine, quantity: 2.4 g/l; isoleucine, quantity: 3 g - injection, intravenous infusion - excipient ingredients: glacial acetic acid; sodium metabisulfite; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - dibasic potassium phosphate, quantity: 2.61 g/l; lysine hydrochloride, quantity: 3.6 g/l (equivalent: lysine, qty 2.9 g/l); magnesium chloride hexahydrate, quantity: 0.51 g/l; sodium acetate, quantity: 3.4 g/l; threonine, quantity: 2.1 g/l; isoleucine, quantity: 3 g/l; proline, quantity: 3.4 g/l; glucose, quantity: 125 g/l; alanine, quantity: 10.35 g/l; sodium chloride, quantity: 0.59 g/l; serine, quantity: 2.5 g/l; methionine, quantity: 2 g/l; phenylalanine, quantity: 2.8 g/l; glycine, quantity: 5.15 g/l; - injection, intravenous infusion - excipient ingredients: sodium metabisulfite; glacial acetic acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

reig jofre uk ltd - fluocinolone acetonide; neomycin sulfate - cutaneous ointment - 250microgram/1gram ; 5mg/1gram